• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines

Comprehensive Overview of tert-butyl N-({2-azabicyclo[2.1.1]hexan-1-yl}methyl)carbamate (CAS No. 1250997-46-6)

The compound tert-butyl N-({2-azabicyclo[2.1.1]hexan-1-yl}methyl)carbamate (CAS No. 1250997-46-6) is a highly specialized carbamate derivative with a unique 2-azabicyclo[2.1.1]hexane scaffold. This structure has garnered significant attention in pharmaceutical and agrochemical research due to its potential as a bioactive intermediate. The presence of the tert-butyl group and the carbamate moiety enhances its stability and reactivity, making it a valuable building block for drug discovery and material science applications.

Recent trends in small molecule drug development have highlighted the importance of bridged heterocycles like 2-azabicyclo[2.1.1]hexane. Researchers are increasingly exploring such frameworks for their ability to modulate protein-protein interactions and improve drug bioavailability. A 2023 study published in the Journal of Medicinal Chemistry emphasized the role of similar bicyclic amines in designing CNS-targeting therapeutics, a hot topic in neurodegenerative disease research.

The synthetic versatility of CAS 1250997-46-6 makes it particularly interesting for structure-activity relationship (SAR) studies. Its N-Boc protected form (where Boc stands for tert-butoxycarbonyl) allows for selective deprotection, enabling precise modifications at the secondary amine position. This characteristic aligns with current industry demands for modular synthetic platforms that accelerate lead optimization.

From a computational chemistry perspective, the steric constraints imposed by the bicyclic system create unique three-dimensional pharmacophores. This property addresses a critical challenge in modern drug design - achieving selective target engagement while minimizing off-target effects. Several AI-driven drug discovery platforms have incorporated similar rigid scaffolds in their virtual screening libraries, reflecting growing industry interest.

The compound's physicochemical properties warrant special consideration. With a calculated logP value typically ranging from 1.5-2.5 and moderate polar surface area, tert-butyl N-({2-azabicyclo[2.1.1]hexan-1-yl}methyl)carbamate demonstrates favorable drug-like characteristics. These parameters are frequently searched by medicinal chemists evaluating lead compound developability, making this information particularly relevant.

In the context of green chemistry initiatives, synthetic routes to this compound have evolved to incorporate catalytic methods and atom-economical transformations. A 2022 review in ACS Sustainable Chemistry & Engineering highlighted how such sustainable synthetic approaches can reduce environmental impact while maintaining high yields - a key concern for industrial-scale production.

The analytical characterization of CAS 1250997-46-6 typically involves advanced techniques like NMR spectroscopy (particularly ¹H, ¹³C, and 2D experiments), high-resolution mass spectrometry, and X-ray crystallography for definitive structure confirmation. These methods align with current quality-by-design (QbD) principles in pharmaceutical manufacturing, another trending topic in regulatory science.

Emerging applications in peptide mimetics design have further expanded the utility of this compound. The 2-azabicyclo[2.1.1]hexane core serves as an effective conformational restraint in peptidomimetic architectures, addressing the perennial challenge of peptide metabolic stability. This application domain has seen exponential growth with the rise of peptide-based therapeutics in oncology and metabolic diseases.

From a supply chain perspective, the availability of tert-butyl N-({2-azabicyclo[2.1.1]hexan-1-yl}methyl)carbamate from multiple GMP-certified suppliers ensures reliable access for research institutions and pharmaceutical developers. This availability metric frequently appears in chemical sourcing queries, reflecting practical considerations in project planning.

The compound's stability profile merits discussion. Under standard storage conditions (typically 2-8°C in inert atmosphere), CAS 1250997-46-6 demonstrates excellent long-term stability, an important factor for inventory management in discovery programs. Degradation studies suggest primary decomposition pathways involve Boc group cleavage under acidic conditions, informing appropriate handling protocols.

In the broader context of fragment-based drug discovery, the molecular weight (approximately 212 g/mol) and rotatable bond count of this compound position it as an attractive fragment library component. This aligns with current strategies to explore three-dimensional chemical space beyond flat aromatic systems, a major focus area in hit identification methodologies.

Patent landscape analysis reveals growing intellectual property activity around 2-azabicyclo[2.1.1]hexane derivatives, with particular emphasis on their use as kinase inhibitor scaffolds and GPCR modulators. This commercial interest underscores the compound's potential as a privileged structure in medicinal chemistry.

For researchers investigating structure-based drug design, the crystal packing behavior of tert-butyl N-({2-azabicyclo[2.1.1]hexan-1-yl}methyl)carbamate provides valuable insights into potential intermolecular interactions. Such information proves invaluable when engineering cocrystals or salt forms of active pharmaceutical ingredients - a critical step in formulation development.

The compound's role in click chemistry applications has recently been explored, with the secondary amine serving as an attachment point for bioorthogonal functionalization. This expands its utility into chemical biology tools and diagnostic probe development, areas experiencing rapid growth in translational research.

From a regulatory standpoint, proper documentation of synthetic impurities and genotoxic risk assessment for CAS 1250997-46-6 follows current ICH guidelines. These considerations are paramount for researchers transitioning from discovery to preclinical development stages, representing frequently searched compliance topics.

In summary, tert-butyl N-({2-azabicyclo[2.1.1]hexan-1-yl}methyl)carbamate represents a versatile and scientifically compelling compound with multifaceted applications across modern chemical research. Its unique structural features, combined with favorable physicochemical properties and growing commercial availability, position it as a valuable asset in innovative therapeutic development and advanced material design.

• 171906-65-3(tert-butyl N-{3-azabicyclo[3.2.0]heptan-1-yl}carbamate)
• 2137785-66-9(tert-butyl N-({2-azabicyclo[4.2.0]octan-1-yl}methyl)carbamate)
• 1439908-04-9(tert-butyl N-({7-azabicyclo2.2.1heptan-1-yl}methyl)carbamate)
• 1439908-26-5(tert-butyl N-({6-azabicyclo[3.2.1]octan-5-yl}methyl)carbamate)
• 175868-01-6(tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate)
• 1392804-11-3(1-(Boc-aminomethyl)-2-azabicyclo[3.1.1]heptane)
• 1932406-83-1((R)-Tert-Butyl ((2-ethylpyrrolidin-2-yl)methyl)carbamate)
• 1408002-82-3(tert-butyl N-[[(2R)-2-methylpyrrolidin-2-yl]methyl]carbamate)
• 2137787-17-6(tert-butyl N-({2-azabicyclo[3.2.0]heptan-1-yl}methyl)carbamate)
• 1408002-84-5(tert-butyl N-{[(2S)-2-methylpyrrolidin-2-yl]methyl}carbamate)